Search

everythinglearnresearchcommunity

for

Search:↓

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

MSM supplementation in kittens improves hair quality and growth rate without harming their health.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

New understanding and treatments for hair loss are improving, but more research is needed.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

More precise, personalized therapies are needed for autoimmune diseases.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Entospletinib effectively prevents eye and skin GVHD in mice.

Chicken feather growth involves specific genes and shares similarities with hair development.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Similar treatments might work for different types of scarring hair loss.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Vitamin A is important for healthy skin and hair, influencing hair growth and skin healing, but UV light reduces its levels.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.